A nested case-control study of factors contributing to the development of medication-related osteonecrosis of the jaw in patients using bone resorption inhibitors in Mishima City.

Journal of oral science(2023)

Cited 1|Views4
No score
Abstract
High-dose bisphosphonates may be a risk factor for the development of MRONJ. Patients who use these products require careful prophylactic dental treatment against inflammatory diseases, and dentists and physicians should maintain close communication.
More
Translated text
Key words
bisphosphonate, counter matching, denosumab, drug holidays, nested case-control study, osteonecrosis of the jaw
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined